Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.

Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.
复制标题

DOI:
10.1371/journal.pgen.1001213
复制
发表时间:
2010-11-18
期刊:
影响因子:
4.5
通讯作者:
Gieger C
Gieger C
中科院分区:
生物学2区
文献类型:
--
作者:
Marzi C;Albrecht E;Hysi PG;Lagou V;Waldenberger M;Tönjes A;Prokopenko I;Heim K;Blackburn H;Ried JS;Kleber ME;Mangino M;Thorand B;Peters A;Hammond CJ;Grallert H;Boehm BO;Kovacs P;Geistlinger L;Prokisch H;Winkelmann BR;Spector TD;Wichmann HE;Stumvoll M;Soranzo N;März W;Koenig W;Illig T;Gieger C

文献摘要

参考文献

被引文献

相似文献

急性期血清淀粉样蛋白A(A-SAA)水平升高可引起淀粉样变性,是动脉粥样硬化及其临床并发症、2型糖尿病以及各种恶性肿瘤的危险因素。为了研究A-SAA水平的遗传基础,我们在三项基于人群的研究(KORA,TwinsUK,Sorbs)和一项前瞻性病例队列研究(LURIC)中对基线A-SAA浓度进行了首次全基因组关联研究,共包括4,212名欧洲血统的参与者,并在11p15.5-p13和1 p31处确定了两个新的遗传易感区域。11 p15.5-p13(rs 4150642; p = 3.20×10−111)区域包含血清淀粉样蛋白A1(SAA 1)和相邻的一般转录因子2 H1(GTF 2 H1)、赫-普综合征5(HPS 5)、乳酸脱氢酶A(LDHA)和乳酸脱氢酶C(LDHC)。  该区域解释了我们数据中A-SAA水平总变异的10.84%,占总估计遗传力的18.37%。第二个区域在1 p31(rs 12753193; p = 1.22×10−11)处包含瘦素受体(LEPR)基因,并且在先前的研究中发现与CRP和纤维蛋白原相关。  我们的研究结果表明11p15.5-p13区域在调节基线A-SAA水平中的关键作用,并为1 p31区域在炎症过程中的重要性以及A-SAA、瘦素和其他急性期蛋白之间的密切相互作用提供了确凿的证据。急性期血清淀粉样蛋白A(A-SAA)水平升高,急性炎症状态的敏感标志物,具有高遗传性估计,导致淀粉样变性,是动脉粥样硬化及其临床并发症,2型糖尿病,以及各种恶性肿瘤的危险因素。这项研究描述了第一个关于基线A-SAA浓度的全基因组关联研究。在对总计4,212名欧洲血统参与者的四次全基因组扫描的荟萃分析中,我们在11号和1号染色体上发现了两个与基线A-SAA浓度相关的新的遗传易感区域。11号染色体区域包含血清淀粉样蛋白A1基因和邻近基因,并解释了总估计遗传率的高百分比。1号染色体区域是已知的炎症遗传易感性区域。总之,我们确定了一个区域,这似乎是在A-SAA水平的调节中的关键重要性,并代表了一个新的潜在目标,为相关的临床实体的调查。此外,我们的研究结果表明A-SAA和其他炎症蛋白之间存在密切的相互作用,以及已知的遗传易感性区域在炎症过程中的作用更大,因为它在过去一直被认为是。
Elevated levels of acute-phase serum amyloid A (A-SAA) cause amyloidosis and are a risk factor for atherosclerosis and its clinical complications, type 2 diabetes, as well as various malignancies. To investigate the genetic basis of A-SAA levels, we conducted the first genome-wide association study on baseline A-SAA concentrations in three population-based studies (KORA, TwinsUK, Sorbs) and one prospective case cohort study (LURIC), including a total of 4,212 participants of European descent, and identified two novel genetic susceptibility regions at 11p15.5-p13 and 1p31. The region at 11p15.5-p13 (rs4150642; p = 3.20×10−111) contains serum amyloid A1 (SAA1) and the adjacent general transcription factor 2 H1 (GTF2H1), Hermansky-Pudlak Syndrome 5 (HPS5), lactate dehydrogenase A (LDHA), and lactate dehydrogenase C (LDHC). This region explains 10.84% of the total variation of A-SAA levels in our data, which makes up 18.37% of the total estimated heritability. The second region encloses the leptin receptor (LEPR) gene at 1p31 (rs12753193; p = 1.22×10−11) and has been found to be associated with CRP and fibrinogen in previous studies. Our findings demonstrate a key role of the 11p15.5-p13 region in the regulation of baseline A-SAA levels and provide confirmative evidence of the importance of the 1p31 region for inflammatory processes and the close interplay between A-SAA, leptin, and other acute-phase proteins. An elevated level of acute-phase serum amyloid A (A-SAA), a sensitive marker of the acute inflammatory state with high heritability estimates, causes amyloidosis and is a risk factor for atherosclerosis and its clinical complications, type 2 diabetes, as well as various malignancies. This study describes the first genome-wide association study on baseline A-SAA concentrations. In a meta-analysis of four genome-wide scans totalling 4,212 participants of European descent, we identified two novel genetic susceptibility regions on chromosomes 11 and 1 to be associated with baseline A-SAA concentrations. The chromosome 11 region contains the serum amyloid A1 gene and the adjacent genes and explains a high percentage of the total estimated heritability. The chromosome 1 region is a known genetic susceptibility region for inflammation. Taken together, we identified one region, which seems to be of key importance in the regulation of A-SAA levels and represents a novel potential target for the investigation of related clinical entities. In addition, our findings indicate a close interplay between A-SAA and other inflammatory proteins, as well as a larger role of a known genetic susceptibility region for inflammatory processes as it has been assumed in the past.
DOI: 10.1038/ng2088
发表时间: 2007-07-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Marchini, Jonathan;Howie, Bryan;Donnelly, Peter
通讯作者: Donnelly, Peter
DOI: 10.1161/01.cir.0000163569.97918.c0
发表时间: 2005-05-03
期刊: CIRCULATION
影响因子: 37.8
作者:
Schillinger, M;Exner, M;Minar, E
通讯作者: Minar, E
DOI: 10.1136/bmj.321.7255.199
发表时间: 2000-07-22
影响因子: 105.7
作者:
Danesh, J;Whincup, P;Pepys, MB
通讯作者: Pepys, MB
DOI: 10.1161/01.cir.98.9.839
发表时间: 1998-09-01
期刊: CIRCULATION
影响因子: 37.8
作者:
Ridker, PM;Rifai, N;Braunwald, E
通讯作者: Braunwald, E
DOI: 10.1161/01.cir.0000115516.54550.b1
发表时间: 2004-02-17
期刊: CIRCULATION
影响因子: 37.8
作者:
Johnson, BD;Kip, KE;Reis, SE
通讯作者: Reis, SE